Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm studyLancet Respir Med - Davies, J C; Cunningham, S; Harris, W T (2016)
et al.